Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18073625 | 0.82 | TDP1 (0.53) | TDP1LMNATP53CASP3ALDH1A1 | |
| SCHEMBL166122 | 0.81 | TDP1 (0.57) | TDP1LMNATP53CASP3ALDH1A1 | |
| SCHEMBL29381145 | 0.81 | TDP1 (0.57) | TDP1LMNATP53CASP3ALDH1A1 | |
| SCHEMBL6656473 | 0.81 | TDP1 (0.57) | TDP1LMNATP53CASP3ALDH1A1 | |
| SCHEMBL16165679 | 0.79 | POLB (0.52) | TDP1LMNATP53ALDH1A1POLB | |
| SCHEMBL16165681 | 0.79 | POLB (0.52) | TDP1LMNATP53ALDH1A1POLB | |
| SCHEMBL1892274 | 0.79 | TDP1 (0.55) | TDP1LMNATP53CASP3ALDH1A1 | |
| SCHEMBL17916020 | 0.78 | TDP1 (0.50) | TDP1LMNATP53CASP3ALDH1A1 | |
| SCHEMBL19500155 | 0.78 | TDP1 (0.50) | TDP1LMNATP53CASP3ALDH1A1 | |
| SCHEMBL13324551 | 0.78 | TDP1 (0.50) | TDP1LMNATP53CASP3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051310-B2 | Nicotinamide derivative or salt thereof | FUJIFILM CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20140309225-A1 | NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309225-A1 | NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF | SYK, BTK, NOX4 | TDP1 1179/4885LMNA 4440/4885TP53 2270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.